Abstract
In the presence of a commercially available Cinchona alkaloid as catalyst, the asymmetric allylic alkylation of Morita–Baylis–Hillman carbonates, with α-fluoro-β-keto esters as nucleophiles, have been successfully developed. A series of important fluorinated adducts, with chiral quaternary carbon centres containing a fluorine atom, was achieved in good yields (up to 93%), with good to excellent enantioselectivities (up to 96% ee) and moderate diastereoselectivities (up to 4:1 dr).
Keywords: allylic alkylation, asymmetric catalysis, fluorine, fluoro-β-keto esters, Morita–Baylis–Hillman carbonates, natural product
Introduction
Fluorine is the most electronegative element in the periodic table, resulting in a highly polar C–F bond. This gives fluoro-organic compounds unique properties, compared with their parent compounds [1]. Due to the rareness of organofluorine compounds in nature, synthetic fluorinated compounds have been widely applied in numerous areas, including materials, agrochemicals, pharmaceuticals and fine chemicals [2–4]. In this context, the stereoselective introduction of fluorine atoms in molecules has become one of the most exciting and intense research areas in the recent years.
Lewis base-catalyzed asymmetric allylic alkylations (AAA) of Morita–Baylis–Hillman (MBH) adducts [5–6], such as acetates and carbonates, have become an attractive option to access various chiral C- [7–19], N- [20–25], O- [26–30], P- [31–33] and S-allylic [34] and spirocyclic compounds [35–37]. Several protocols have been established to introduce fluorine atoms in AAA of MBH adducts. For example, to introduce a CF3 group, Shibata and co-workers [13] and Jiang and co-workers [14] successively reported the asymmetric allylic trifluoromethylation of MBH adducts with Ruppert’s reagent [(trifluoromethyl)trimethylsilane, Me3SiCF3] in the presence of (DHQD)2PHAL as catalyst. In 2011, our research group [15], Shibata and co-workers [16] and Rios and co-workers [17] reported the addition of fluoromethyl(bisphenylsulfones) to MBH carbonates to access chiral monofluoromethyl derivatives. Furthermore, Rios and co-workers presented an asymmetric substitution of MBH carbonates with 2-fluoromalonates in good enantioselectivities [38]. Notably, the reaction between an achiral fluorocarbon nucleophile with MBH carbonates, to afford compounds with chiral quaternary carbon centres bearing a fluorine atom, remains a formidable task. Since 2009, we developed a highly enantioselective and diastereoselective guanidine-catalyzed conjugate addition and Mannich reaction of α-fluoro-β-ketoesters with excellent results [38–40]. Herein, we wish to report the first allylic alkylation of MBH carbonates with α-fluoro-β-ketoesters in excellent enantioselectivities and moderate diastereoselectivities, furnishing enantiopure fluorinated compounds with chiral quaternary carbon centres containing a fluorine atom.
Results and Discussion
In the preliminary experiments, we investigated the reaction of α-fluoro-β-ketoester 1a with MBH carbonate 2a as the model substrate, in the presence of several commercially available Cinchona alkaloids as Lewis base catalysts (Table 1). First, the reaction was conducted in the presence of quinine at 50 °C in dichloroethane (DCE) as the solvent (Table 1, entry 1). The desired adduct 3aa was obtained in 53% yield with poor enantio- and diastereoselectivity. Cinchonine provided similarly poor results (Table 1, entry 2). Next, we screened a series of C2-symmetric bis-Cinchona alkaloids as catalysts under the same conditions (Table 1, entries 3–7). (DHQD)2PHAL showed moderate catalytic activity; 3aa was obtained in 67% yield with 71% ee and 60:40 dr (entry 3). The effects of solvent were then investigated (Table 1, entries 8–18). The best-performing solvent was mesitylene with respect to enantio- and diastereoselectivity; providing 3aa in 78% yield with 89% ee and 71:29 dr (entry 18). The reaction temperature can be decreased to 25 °C and 67% yield of 3aa with 92% ee and 74:26 dr was obtained (entry 19). A slight increase in enantio- and diastereoselectivity could be obtained when the reaction temperature was decreased to 10 °C, but the reaction rate became too sluggish to be useful (Table 1, entry 20).
Table 1.
Catalyst screeninga.
![]() | |||||
| Entry | Catalyst | Solvent | Yield (%)b | ee (%)c | drc |
| 1 | quinine | DCE | 53 | 32 (27) | 55:45 |
| 2 | cinchonine | DCE | 59 | 21 (10) | 55:45 |
| 3 | (DHQD)2PHAL | DCE | 67 | 71 (57) | 60:40 |
| 4 | (DHQD)2AQN | DCE | 53 | –5 (–5) | 56:44 |
| 5 | (DHQ)2PHAL | DCE | 64 | –35 (–1) | 52:48 |
| 6 | (DHQ)2PYR | DCE | 60 | –25 (–1) | 59:41 |
| 7 | (DHQ)2AQN | DCE | 47 | –11 (–10) | 55:45 |
| 8 | (DHQD)2PHAL | DCM | 56 | 69 (55) | 58:42 |
| 9 | (DHQD)2PHAL | toluene | 78 | 85 (65) | 67:33 |
| 10 | (DHQD)2PHAL | Et2O | 59 | 45 (30) | 55:45 |
| 11 | (DHQD)2PHAL | EA | 58 | 55 (30) | 55:45 |
| 12 | (DHQD)2PHAL | THF | 61 | 31 (49) | 63:37 |
| 13 | (DHQD)2PHAL | MeCN | 57 | 49 (19) | 65:35 |
| 14 | (DHQD)2PHAL | MeOH | 63 | 35 (20) | 60:40 |
| 15 | (DHQD)2PHAL | o-xylene | 74 | 85 (65) | 72:28 |
| 16 | (DHQD)2PHAL | m-xylene | 65 | 87 (74) | 70:30 |
| 17 | (DHQD)2PHAL | p-xylene | 72 | 85 (55) | 68:32 |
| 18 | (DHQD)2PHAL | mesitylene | 78 | 89 (72) | 71:29 |
| 19d | (DHQD)2PHAL | mesitylene | 67 | 92 (69) | 74:26 |
| 20e | (DHQD)2PHAL | mesitylene | 45 | 94 (55) | 75:25 |
aUnless otherwise noted, reactions were performed with 0.05 mmol of 1a, 0.15 of 2a, and 0.005 mmol of catalyst in 0.5 mL solvent. bYield of isolated product. cDetermined by HPLC methods. The data in parenthesis is the ee value of the minor diastereoisomer dThe reaction was conducted at 25 °C, 1.0 mmol scale in 1.0 mL of mesitylene. eThe reaction was conducted at 10 °C, 1.0 mmol scale in 1.0 mL of mesitylene.
Using the established conditions, allylic alkylations of α-fluoro-β-ketoesters 1b–g with MBH carbonate 2a were found to afford the products 3ba–ga in 67–79% yield with 88–96% ee and 3:1 to 4:1 dr (Table 2, entries 1–6). The results showed that the introduction of various aryl substituents in α-fluoro-β-ketoesters did not affect the reactivity and stereoselectivity. Subsequently, the scope of the allylic alkylation with respect to various MBH carbonates 2 and α-fluoro-β-ketoester 1a was investigated (Table 2, entries 7–20). The desired allylic alkylation adducts 3ab–o were achieved in moderate to good yields with good to excellent enantioselectivities and moderate diastereoselectivities. MBH carbonates (Table 2, 2b–k) with electron-withdrawing groups appended on the aromatic rings were more active than those (Table 2, 2l–m) with electron-neutral and donating groups. Excellent ee values with moderate dr values were obtained when the phenyl groups of MBH carbonates were replaced with hetereoaromatic groups, such as thiophene and furan (Table 2, 2n–o).
Table 2.
Allylic alkylation of α-fluoro-β-ketoesters 1 with MBH carbonates 2a.
![]() | |||||||
| Entry | Ar1, 1 | Ar2, 2 | Time (h) | 3 | Yield (%)b | ee (%)c | drd |
| 1 | p-FPh, 1b | Ph, 2a | 40 | 3ba | 71 | 88 | 3:1 |
| 2 | p-ClPh, 1c | Ph, 2a | 70 | 3ca | 79 | 93 | 3:1 |
| 3 | p-BrPh, 1d | Ph, 2a | 70 | 3da | 75 | 96 | 3:1 |
| 4 | m-BrPh, 1e | Ph, 2a | 70 | 3ea | 72 | 90 | 3:1 |
| 5 | 3,5-Cl2Ph, 1f | Ph, 2a | 70 | 3fa | 69 | 88 | 3:1 |
| 6 | p-MePh, 1g | Ph, 2a | 50 | 3ga | 67 | 94 | 4:1 |
| 7 | Ph, 1a | p-NO2Ph, 2b | 70 | 3ab | 91 | 95 | 3:1 |
| 8 | Ph, 1a | p-CF3Ph, 2c | 70 | 3ac | 65 | 87 | 4:1 |
| 9 | Ph, 1a | p-FPh, 2d | 70 | 3ad | 71 | 90 | 3:1 |
| 10 | Ph, 1a | p-ClPh, 2e | 70 | 3ae | 73 | 93 | 4:1 |
| 11 | Ph, 1a | p-BrPh, 2f | 96 | 3af | 64 | 91 | 4:1 |
| 12 | Ph, 1a | m-NO2Ph, 2g | 96 | 3ag | 93 | 95 | 3:1 |
| 13 | Ph, 1a | m-ClPh, 2h | 70 | 3ah | 81 | 91 | 3:1 |
| 14 | Ph, 1a | m-BrPh, 2i | 70 | 3ai | 78 | 90 | 4:1 |
| 15 | Ph, 1a | o-FPh, 2j | 96 | 3aj | 73 | 86 | 4:1 |
| 16 | Ph, 1a | o-ClPh, 2k | 70 | 3ak | 84 | 86 | 4:1 |
| 17 | Ph, 1a | p-MePh, 2l | 70 | 3al | 53 | 91 | 4:1 |
| 18 | Ph, 1a | p-MeOPh, 2m | 70 | 3am | 50 | 91 | 3:1 |
| 19 | Ph, 1a | 2-thienyl, 2n | 90 | 3an | 78 | 92 | 4:1 |
| 20 | Ph, 1a | 2-furyl, 2o | 96 | 3ao | 73 | 84 | 3:1 |
aReactions were performed with 0.1 mmol of 1, 0.3 mmol of 2, and 0.005 mmol of (DHQD)2PHAL in 1.0 mL mesitylene. bYield of isolated product. cDetermined by chiral HPLC on the major diastereoisomer. dDetermined by 1H NMR analysis.
Conclusion
We have developed an asymmetric allylic alkylation of MBH carbonates with α-fluoro-β-ketoesters, catalyzed by a commercially available Cinchona alkaloid. Several fluorinated adducts, with chiral quaternary carbon centres containing a fluorine atom, were successfully prepared in 50–93% yields with 84–96% ee and a dr of 3:1 to 4:1. The absolute configurations of adducts still have to be determined and will be reported in due course.
Experimental
Representative procedure for the synthesis of 3aa: α-Fluoro-β-ketoester 1a (21.0 mg, 1.0 equiv, 0.1 mmol) and (DHQD)2PHAL (7.8 mg, 0.1 equiv, 0.01 mmol) were dissolved in mesitylene (1.0 mL) at 25 °C. After the addition of MBH carbonate 2a (3.0 equiv, 0.3 mmol) the reaction mixture was stirred at 25 °C. The reaction was monitored by TLC. After 96 hours, flash chromatography affords product 3aa (25.7 mg, 67% yield) as colorless oil.
Supporting Information
Experimental details and spectroscopic data.
Acknowledgments
This work was supported by NSFC (nos. 21072044, 21202034), the Program for New Century Excellent Talents in University of the Ministry of Education (NCET-11-0938) and Excellent Youth Foundation of Henan Scientific Committee (114100510003). Z.J. also appreciates the generous financial support from Nanyang Technological University for the senior research fellow funding.
This article is part of the Thematic Series "Transition-metal and organocatalysis in natural product synthesis".
Contributor Information
Choon-Hong Tan, Email: choonhong@ntu.edu.sg.
Zhiyong Jiang, Email: chmjzy@henu.edu.cn.
References
- 1.O’Hagan D. Chem Soc Rev. 2008;37:308–319. doi: 10.1039/b711844a. [DOI] [PubMed] [Google Scholar]
- 2.Hiyama T. Organofluorine Compounds: Chemistry and Applications. Berlin: Springer; 2000. [DOI] [Google Scholar]
- 3.Uneyama K. Organo-fluorine Chemisry. Oxford: Blackwell; 2006. [Google Scholar]
- 4.Filler R, Kobayashi Y, Yagupolskii L M, editors. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications. Elservier; 1993. [Google Scholar]
- 5.Rios R. Catal Sci Technol. 2012;2:267–278. doi: 10.1039/c1cy00387a. [DOI] [Google Scholar]
- 6.Liu T-Y, Xie M, Chen Y-C. Chem Soc Rev. 2012;41:4101–4112. doi: 10.1039/c2cs35017c. [DOI] [PubMed] [Google Scholar]
- 7.Cho C-W, Krische M J. Angew Chem, Int Ed. 2004;43:6689–6691. doi: 10.1002/anie.200461381. [DOI] [PubMed] [Google Scholar]
- 8.van Steenis D J V C, Marcelli T, Lutz M, Spek A L, van Maarseveen J H, Hiemstra H. Adv Synth Catal. 2007;349:281–286. doi: 10.1002/adsc.200600467. [DOI] [Google Scholar]
- 9.Jiang Y-Q, Shi Y-L, Shi M. J Am Chem Soc. 2008;130:7202–7203. doi: 10.1021/ja802422d. [DOI] [PubMed] [Google Scholar]
- 10.Cui H-L, Peng J, Feng X, Du W, Jiang K, Chen Y-C. Chem–Eur J. 2009;15:1574–1577. doi: 10.1002/chem.200802534. [DOI] [PubMed] [Google Scholar]
- 11.Jiang K, Peng J, Cui H-L, Chen Y-C. Chem Commun. 2009;45:3955–3957. doi: 10.1039/b905177e. [DOI] [PubMed] [Google Scholar]
- 12.Cui H-L, Huang J-R, Lei J, Wang Z-F, Chen S, Wu L, Chen Y-C. Org Lett. 2010;12:720–723. doi: 10.1021/ol100014m. [DOI] [PubMed] [Google Scholar]
- 13.Furukawa T, Nishimine T, Tokunaga E, Hasegawa K, Shiro M, Shibata N. Org Lett. 2011;13:3972–3975. doi: 10.1021/ol201490e. [DOI] [PubMed] [Google Scholar]
- 14.Li Y, Liang F, Li Q, Xu Y-C, Wang Q-R, Jiang L. Org Lett. 2011;13:6082–56085. doi: 10.1021/ol202572u. [DOI] [PubMed] [Google Scholar]
- 15.Yang W, Wei X, Pan Y, Lee R, Zhu B, Liu H, Yan L, Huang K-W, Jiang Z, Tan C-H. Chem–Eur J. 2011;17:8066–8070. doi: 10.1002/chem.201100929. [DOI] [PubMed] [Google Scholar]
- 16.Furukawa T, Kawazoe J, Zhang W, Nishimine T, Tojunaga E, Matsumoto T, Shiro M, Shibata N. Angew Chem, Int Ed. 2011;50:9684–9688. doi: 10.1002/anie.201103748. [DOI] [PubMed] [Google Scholar]
- 17.Company X, Valero G, Ceban V, Calvet T, Font-Bardía M, Moyano A, Rios R. Org Biomol Chem. 2011;9:7986–7989. doi: 10.1039/C1OB06308A. [DOI] [PubMed] [Google Scholar]
- 18.Yang W, Tan D, Li L, Han Z, Yan L, Huang K-W, Tan C-H, Jiang Z. J Org Chem. 2012;77:6600–6607. doi: 10.1021/jo3012539. [DOI] [PubMed] [Google Scholar]
- 19.Tong G, Zhu B, Lee R, Yang W, Tan D, Yang C, Han Z, Yan L, Huang K-W, Jiang Z. J Org Chem. 2013;78:5067–5072. doi: 10.1021/jo400496z. [DOI] [PubMed] [Google Scholar]
- 20.Cho C-W, Kong J-R, Krische M J. Org Lett. 2004;6:1337–1339. doi: 10.1021/ol049600j. [DOI] [PubMed] [Google Scholar]
- 21.Park H, Cho C-W, Krische M J. J Org Chem. 2006;71:7892–7894. doi: 10.1021/jo061218s. [DOI] [PubMed] [Google Scholar]
- 22.Cui H-L, Feng X, Peng J, Lei J, Jiang K, Chen Y-C. Angew Chem, Int Ed. 2009;48:5737–5740. doi: 10.1002/anie.200902093. [DOI] [PubMed] [Google Scholar]
- 23.Huang J-R, Cui H-L, Lei J, Sun X-H, Chen Y-C. Chem Commun. 2011;47:4784–4786. doi: 10.1039/c0cc05616b. [DOI] [PubMed] [Google Scholar]
- 24.Deng H-P, Wei Y, Shi M. Eur J Org Chem. 2011:1956–1960. doi: 10.1002/ejoc.201001660. [DOI] [Google Scholar]
- 25.Lin A, Mao H, Zhu X, Ge H, Tan R, Zhu C, Cheng Y. Chem–Eur J. 2011;17:13676–13679. doi: 10.1002/chem.201102522. [DOI] [PubMed] [Google Scholar]
- 26.Trost B M, Tsui H-C, Toste F D. J Am Chem Soc. 2000;122:3534–3535. doi: 10.1021/ja994326n. [DOI] [Google Scholar]
- 27.Kim J N, Lee H J, Gong J H. Tetrahedron Lett. 2002;43:9141–9146. doi: 10.1016/S0040-4039(02)02274-8. [DOI] [Google Scholar]
- 28.Feng X, Yuan Y-Q, Jiang K, Chen Y-C. Org Biomol Chem. 2009;7:3660–3662. doi: 10.1039/b912110b. [DOI] [PubMed] [Google Scholar]
- 29.Hu Z, Cui H, Jiang K, Chen Y. Sci China, Ser B: Chem. 2009;52:1309–1313. doi: 10.1007/s11426-009-0187-8. [DOI] [Google Scholar]
- 30.Zhu B, Yan L, Pan Y, Lee R, Liu H, Han Z, Huang K-W, Tan C-H, Jiang Z. J Org Chem. 2011;76:6894–6900. doi: 10.1021/jo201096e. [DOI] [PubMed] [Google Scholar]
- 31.Hong L, Sun W, Liu C, Zhao D, Wang R. Chem Commun. 2010;46:2856–2858. doi: 10.1039/b926037d. [DOI] [PubMed] [Google Scholar]
- 32.Sun W, Hong L, Liu C, Wang R. Org Lett. 2010;12:3914–3917. doi: 10.1021/ol101601d. [DOI] [PubMed] [Google Scholar]
- 33.Deng H-P, Shi M. Eur J Org Chem. 2012;2012:183–187. doi: 10.1002/ejoc.201101365. [DOI] [Google Scholar]
- 34.Lin A, Mao H, Zhu X, Ge H, Tan R, Zhu C, Cheng Y. Adv Synth Catal. 2011;353:3301–3306. doi: 10.1002/adsc.201100522. [DOI] [Google Scholar]
- 35.Tan B, Candeias N R, Barbas C F., III J Am Chem Soc. 2011;133:4672–4675. doi: 10.1021/ja110147w. [DOI] [PubMed] [Google Scholar]
- 36.Zhong F, Han X, Wang Y, Lu Y. Angew Chem, Int Ed. 2011;50:7837–7841. doi: 10.1002/anie.201102094. [DOI] [PubMed] [Google Scholar]
- 37.Peng J, Huang X, Jiang L, Cui H-L, Chen Y-C. Org Lett. 2011;13:4584–4587. doi: 10.1021/ol201776h. [DOI] [PubMed] [Google Scholar]
- 38.Wang B, Comany X, Li J, Moyano A, Rios R. Tetrahedron Lett. 2012;53:4124–4129. doi: 10.1016/j.tetlet.2012.05.121. [DOI] [Google Scholar]
- 39.Jiang Z, Pan Y, Zhao Y, Ma T, Lee R, Yuang Y, Huang K-W, Wong M W, Tan C-H. Angew Chem, Int Ed. 2009;48:3627–3631. doi: 10.1002/anie.200900964. [DOI] [PubMed] [Google Scholar]
- 40.Pan Y, Zhao Y, Ma T, Yang Y, Liu H, Jiang Z, Tan C-H. Chem–Eur J. 2010;16:779–782. doi: 10.1002/chem.200902830. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental details and spectroscopic data.


